HIGHLIGHTS
- who: Simona Rabinovici-Cohen and colleagues from the Institut Curie, Rue d`Ulm, Paris, France Faculty of Medicine, The Hebrew University, Jerusalem, Israel have published the Article: Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy, in the Journal: Cancers 2022, 3848 of /2022/
- what: The authors explore the use of clinical history immunohistochemical markers and multiparametric magnetic resonance imaging (DCE ADC Dixon) to predict the risk of post-treatment within years. The study described in this paper holds the promise of identifying novel composite prognostic biomarkers that would enable . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.